S C Hughan1, S P Watson. 1. Centre for Cardiovascular Sciences, Institute of Biomedical Research, University of Birmingham, Birmingham, UK. sascha.hughan@med.monash.edu.au
Abstract
BACKGROUND: We previously demonstrated that Dok2 is rapidly phosphorylated on tyrosine residues in platelets in response to thrombin, the immunoreceptor tyrosine-based activation motif-coupled collagen receptor glycoprotein (GP) VI, and by integrin alphaIIbbeta3. OBJECTIVES AND METHODS: In this study we further delineate the regulation of phosphorylation of Dok2 and compare this to the related adapter Dok1. RESULTS: We demonstrate expression of Dok1 in platelets and the unexpected observation that the adapter protein undergoes tyrosine phosphorylation in response to thrombin but not to GPVI or integrin alphaIIbbeta3. Furthermore, Dok1 phosphorylation is transient, peaking at 30 s and returning to basal by 5 min, whereas Dok2 phosphorylation is delayed but sustained. Dok2 phosphorylation, but not that of Dok1, is inhibited by Src kinase inhibitors and by chelation of intracellular calcium. Further, phosphorylation of Dok2 by thrombin and integrin alphaIIbbeta3 in mouse platelets is independent of Syk and phospholipase Cgamma2. Additionally, Dok2 coimmunoprecipitates with integrin alphaIIbbeta3 downstream of Src kinases. CONCLUSIONS: These results demonstrate differential modes of regulation of Dok1 and Dok2 in platelets. Further, they raise the interesting possibility that Dok2 plays an important role in integrin outside-in signaling through a physical and functional interaction with integrin alphaIIbbeta3.
BACKGROUND: We previously demonstrated that Dok2 is rapidly phosphorylated on tyrosine residues in platelets in response to thrombin, the immunoreceptor tyrosine-based activation motif-coupled collagen receptor glycoprotein (GP) VI, and by integrin alphaIIbbeta3. OBJECTIVES AND METHODS: In this study we further delineate the regulation of phosphorylation of Dok2 and compare this to the related adapter Dok1. RESULTS: We demonstrate expression of Dok1 in platelets and the unexpected observation that the adapter protein undergoes tyrosine phosphorylation in response to thrombin but not to GPVI or integrin alphaIIbbeta3. Furthermore, Dok1 phosphorylation is transient, peaking at 30 s and returning to basal by 5 min, whereas Dok2 phosphorylation is delayed but sustained. Dok2 phosphorylation, but not that of Dok1, is inhibited by Src kinase inhibitors and by chelation of intracellular calcium. Further, phosphorylation of Dok2 by thrombin and integrin alphaIIbbeta3 in mouse platelets is independent of Syk and phospholipase Cgamma2. Additionally, Dok2 coimmunoprecipitates with integrin alphaIIbbeta3 downstream of Src kinases. CONCLUSIONS: These results demonstrate differential modes of regulation of Dok1 and Dok2 in platelets. Further, they raise the interesting possibility that Dok2 plays an important role in integrin outside-in signaling through a physical and functional interaction with integrin alphaIIbbeta3.
Authors: Sascha C Hughan; Christopher M Spring; Simone M Schoenwaelder; Sharelle Sturgeon; Imala Alwis; Yuping Yuan; James D McFadyen; Erik Westein; Duncan Goddard; Akiko Ono; Yuji Yamanashi; Warwick S Nesbitt; Shaun P Jackson Journal: J Biol Chem Date: 2014-01-02 Impact factor: 5.157
Authors: Masaru Niki; Manasa K Nayak; Hong Jin; Neha Bhasin; Edward F Plow; Pier Paolo Pandolfi; Paul B Rothman; Anil K Chauhan; Steven R Lentz Journal: Thromb Haemost Date: 2016-01-21 Impact factor: 5.249
Authors: Laura M Timmerman; J Fréderique de Graaf; Nikolaos Satravelas; Çan Kesmir; Linde Meyaard; Michiel van der Vlist Journal: PLoS One Date: 2021-03-29 Impact factor: 3.240
Authors: Carly Kempster; George Butler; Elina Kuznecova; Kirk A Taylor; Neline Kriek; Gemma Little; Marcin A Sowa; Tanya Sage; Louise J Johnson; Jonathan M Gibbins; Alice Y Pollitt Journal: Sci Rep Date: 2022-03-17 Impact factor: 4.379